Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 326

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 326
---
     | Brookfield Capital Partners (Uk) Limited   |     |   18,663.8 |     |  7,297.4 |     |  1,368.3 |     |  1,018.6 |
| 06/20/24 |     | Range Impact, Inc. (OCTCPK:RNGE)                                   |     | Continental Heritage Holding Company LLC   |     |       41.6 |     |     20.2 |     |      3.4 |     |      1.3 |
| 06/14/24 |     | Fancl Corporation (TSE:4921)                                       |     | Kirin Holdings Company, Limited (TSE:2503) |     |    2,089.9 |     |    682.4 |     |     98.9 |     |     74.4 |
| 03/12/24 |     | Navamedic ASA (OB:NAVA)                                            |     | —                                          |     |       61.4 |     |     50.5 |     |      5.1 |     |      3.9 |
| 02/22/24 |     | Comvita Limited (NZSE:CVT)                                         |     | —                                          |     |      112.8 |     |    142.8 |     |      7.8 |     |      0.3 |
| 02/21/24 |     | China Traditional Chinese Medicine Holdings Co. Limited (SEHK:570) |     | Sinopharm Common Wealth Company Limited    |     |    3,023.8 |     |  2,555.7 |     |    348.0 |     |    189.7 |

Notes:

| (1) | Values in millions of US dollars. |

186

| (2) | Corresponding Enterprise Value multiples in tables below. |

| (3) | Source: S&P Capital IQ. |

| Date     |     | Target                                          |     | Buyer / Investor                                                                                     |     | Enterprise 
   Value($) |     |    Sales 
 (TTM)($) |     |   EBITDA 
 (TTM)($) |     |     EBIT 
 (TTM)($) |
| 01/12/24 |     | Hanmi Science Co., Ltd. (KOSE:A008